Seeing Is Believing

Currently out of the existing stock ratings of Joshua Jennings, 316 are a BUY (88.27%), 41 are a HOLD (11.45%), 1 are a SELL (0.28%).
Analyst Joshua Jennings, currently employed at TD COWEN, carries an average stock price target met ratio of 53.8% that have a potential upside of 31.9% achieved within 235 days.
Joshua Jennings’s has documented 704 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TMDX, TransMedics Group at 01-Jul-2026.
Analyst best performing recommendations are on DCBO (DOCEBO).
The best stock recommendation documented was for HUMA (HUMACYTE) at 6/25/2024. The price target of $7.5 was fulfilled within 20 days with a profit of $2.57 (52.13%) receiving and performance score of 26.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Sep-2024
$115
$20.88 (22.18%)
$115
17 days ago
(22-Jun-2026)
2/7 (28.57%)
$27.17 (30.93%)
143
Buy Since 02-Jun-2021
$131
$36.88 (39.18%)
$131
2 months 12 days ago
(27-Apr-2026)
9/21 (42.86%)
$38.2 (41.16%)
559
Buy Since 17-Dec-2018
$143
$48.88 (51.93%)
$144
2 months 19 days ago
(20-Apr-2026)
19/31 (61.29%)
$47 (48.96%)
495
Buy Since 18-Jul-2018
$120
$25.88 (27.50%)
$134
2 months 22 days ago
(17-Apr-2026)
10/18 (55.56%)
$23.19 (23.95%)
290
Buy Since 25-May-2021
$120
$25.88 (27.50%)
$150
2 months 22 days ago
(17-Apr-2026)
1/7 (14.29%)
$23.19 (23.95%)
194
Which stock is Joshua Jennings is most bullish on?
Which stock is Joshua Jennings is most reserved on?
What Year was the first public recommendation made by Joshua Jennings?